🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested
This is a randomized, open label study designed to evaluate the efficacy an...
Status
Unknown
Location
Shanghai Pulmonary Hospital
Start Date
2021-02-08
Trial ID
NCT04762030
Treatments Being Tested
Non-small cell lung cancer has the highest morbidity and mortality in China...
Status
Unknown
Location
Multiple Locations
Start Date
2018-08-15
Trial ID
NCT03636685
It has been reported that antiangiogenic drugs combined with chemotherapy a...
Status
Active Not Recruiting
Location
Huai'an First People's Hospital
Start Date
2021-08-24
Trial ID
NCT04807166
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of c...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
Start Date
2026-02-01
Trial ID
NCT07307443
Treatments Being Tested
This is a Phase II, prospective, randomized, open label, controlled, multi-...
Status
Not Yet Recruiting
Location
Tangdu Hospital of the Fourth Millitary Medical University
Start Date
2024-06-30
Trial ID
NCT06475755
Treatments Being Tested
This trial is a Phase 1b/2a/3 trial designed to evaluate the safety and eff...
Status
Unknown
Location
The Oncology Institute of Hope and Innovation
Start Date
2015-12
Trial ID
NCT02584478
The purpose of this study is to evaluate the efficacy and safety of Sintili...
Status
Completed
Location
NeoSACT
Start Date
2021-09-15
Trial ID
NCT04877821
Treatments Being Tested
This clinical study plans to enroll 69 endometrial cancer patients and 5-10...
Status
Terminated
Location
Sun Yat-sen Memorial Hospital
Start Date
2022-08-26
Trial ID
NCT05481645
Lung cancer is the most common cancer, accounting for 20% of cancer-related...
Status
Unknown
Location
The second affiliated Hospital of Xi'an Jiaotong University
Start Date
2019-11-22
Trial ID
NCT04182698
Treatments Being Tested